Panacea Biotec Announces Audited Financial Results and Appoints New Independent Director
Panacea Biotec Limited announced the approval of its standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. Additionally, the company's Board of Directors passed over a dividend for the fiscal year 2025-26 and approved the appointment of Mr. Rajinder Singh Manku as a non-executive independent director.The Board of Directors reviewed the financial results at its meeting held on May 30, 2026. The results, which cover the quarter and full year ended March 31, 2026, are available alongside the Auditors' Report.Key Financial Results Overview
The company reported the following key financial...